| Authors: |
Mattson SA; Department of Psychiatry, Massachusetts General/McLean Hospital, Boston, Massachusetts.; Corresponding Author: Seth A. Mattson, MD, Department of Psychiatry, Massachusetts General/McLean Hospital, Boston, Massachusetts (smattson2@mgh.harvard.edu)., King F; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.; Center for Neuroscience of Psychedelics, Massachusetts General Hospital, Boston, Massachusetts., Tanev KS; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.; The Home Base Program, Boston, Massachusetts.; MGH TBI Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts., Matta SE; Department of Psychiatry, Massachusetts General/McLean Hospital, Boston, Massachusetts.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts., Levy-Carrick NC; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.; Department of Psychiatry, Mass General Brigham AMC, Boston, Massachusetts., Peteet JR; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.; Psychosocial Oncology Fellowship Site Director, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts., Stern TA; Department of Psychiatry, Massachusetts General/McLean Hospital, Boston, Massachusetts.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts. |
